meta:
  schema_version: '1.0'
  cell_type: B_cell
  total_entries: 6
  generated_by: Dawn (literature curation)
  last_updated: '2026-02-13'
perturbations:
- id: CD19_KO_BCELL
  gene: CD19
  gene_full_name: CD19 Molecule
  perturbation_type: knockout
  context: in_vitro
  phenotype_changes:
  - parameter: bcr_signaling
    direction: decrease
    effect_size: -0.6
    confidence: high
  - parameter: activation
    direction: decrease
    effect_size: -0.5
    confidence: high
  cellswarm_mapping:
    behavior_changes:
      signal: -0.2
      proliferate: -0.15
      rest: 0.15
    state_changes:
      activation: -0.35
      antibody_secretion: -0.2
  evidence:
  - description: CD19 in B cell receptor signaling. Tedder. Nat Rev Rheumatol 2009
    pmid: '19798033'
    pmid_verified: true
  notes: CD19 amplifies BCR signaling; loss severely impairs B cell activation
- id: PAX5_KO_BCELL
  gene: PAX5
  gene_full_name: Paired Box 5
  perturbation_type: knockout
  context: in_vitro
  phenotype_changes:
  - parameter: b_cell_identity
    direction: decrease
    effect_size: -0.85
    confidence: high
  - parameter: antibody_production
    direction: decrease
    effect_size: -0.7
    confidence: high
  cellswarm_mapping:
    behavior_changes:
      signal: -0.25
      proliferate: -0.1
      apoptosis: 0.15
    state_changes:
      activation: -0.3
      antibody_secretion: -0.4
  evidence:
  - description: PAX5 as B cell lineage commitment factor. Nutt et al. Nature 1999
    pmid: '10524629'
    pmid_verified: true
  notes: PAX5 is the master regulator of B cell identity; loss causes dedifferentiation
  data_calibration:
    source: Replogle et al. 2022 (Cell), K562 Perturb-seq
    replogle_id: 6092_PAX5_P1P2_ENSG00000196092
    pathway_effects:
      proliferation:
        mean_effect: -0.0097
        max_effect: 0.0486
        min_effect: -0.0573
        n_markers: 6
      apoptosis:
        mean_effect: -0.0023
        max_effect: 0.1341
        min_effect: -0.12
        n_markers: 5
      immune_evasion:
        mean_effect: 0.0236
        max_effect: 0.1253
        min_effect: -0.0915
        n_markers: 3
      migration:
        mean_effect: -0.0265
        max_effect: -0.0265
        min_effect: -0.0265
        n_markers: 1
      inflammation:
        mean_effect: 0.0092
        max_effect: 0.0901
        min_effect: -0.0717
        n_markers: 2
- id: BCL6_OE_BCELL
  gene: BCL6
  gene_full_name: BCL6 Transcription Repressor
  perturbation_type: overexpression
  context: in_vitro
  phenotype_changes:
  - parameter: germinal_center_formation
    direction: increase
    effect_size: 0.7
    confidence: high
  - parameter: affinity_maturation
    direction: increase
    effect_size: 0.55
    confidence: medium
  cellswarm_mapping:
    behavior_changes:
      proliferate: 0.15
      signal: 0.1
    state_changes:
      activation: 0.2
      antibody_secretion: 0.15
  evidence:
  - description: BCL6 in germinal center B cell biology. Basso & Dalla-Favera. Annu
      Rev Immunol 2015
    pmid: '26620759'
    pmid_verified: true
  notes: BCL6 is essential for germinal center formation and antibody affinity maturation
  data_calibration:
    source: Replogle et al. 2022 (Cell), K562 Perturb-seq
    replogle_id: 805_BCL6_P1P2_ENSG00000113916
    pathway_effects:
      proliferation:
        mean_effect: -0.016
        max_effect: 0.0397
        min_effect: -0.1291
        n_markers: 6
      apoptosis:
        mean_effect: -0.0003
        max_effect: 0.0824
        min_effect: -0.0756
        n_markers: 5
      immune_evasion:
        mean_effect: -0.0516
        max_effect: 0.0345
        min_effect: -0.1089
        n_markers: 3
      migration:
        mean_effect: 0.0475
        max_effect: 0.0475
        min_effect: 0.0475
        n_markers: 1
      inflammation:
        mean_effect: -0.007
        max_effect: 0.0628
        min_effect: -0.0768
        n_markers: 2
- id: CD40_STIM_BCELL
  gene: CD40
  gene_full_name: CD40 Molecule
  perturbation_type: drug_inhibition
  context: tumor_infiltrating
  phenotype_changes:
  - parameter: activation
    direction: increase
    effect_size: 0.65
    confidence: high
  - parameter: antigen_presentation
    direction: increase
    effect_size: 0.55
    confidence: high
  - parameter: antibody_production
    direction: increase
    effect_size: 0.5
    confidence: medium
  cellswarm_mapping:
    behavior_changes:
      signal: 0.2
      proliferate: 0.1
    state_changes:
      activation: 0.35
      antibody_secretion: 0.25
  evidence:
  - description: CD40 agonism in anti-tumor immunity. Vonderheide. Clin Cancer Res
      2007
    pmid: '17327609'
    pmid_verified: true
  notes: CD40 stimulation activates B cells as APCs and enhances antibody responses
- id: IL10_OE_BCELL
  gene: IL10
  gene_full_name: Interleukin 10
  perturbation_type: overexpression
  context: tumor_infiltrating
  phenotype_changes:
  - parameter: regulatory_function
    direction: increase
    effect_size: 0.55
    confidence: medium
  - parameter: t_cell_suppression
    direction: increase
    effect_size: 0.45
    confidence: medium
  cellswarm_mapping:
    behavior_changes:
      signal: 0.15
      suppress: 0.1
    state_changes:
      activation: 0.1
      antibody_secretion: -0.05
  evidence:
  - description: Regulatory B cells in cancer. Sarvaria et al. Cell Immunol 2017
    pmid: '28626234'
    pmid_verified: true
  notes: IL-10-producing Bregs suppress anti-tumor immunity; enriched in some tumor
    types
- id: CXCR5_OE_BCELL
  gene: CXCR5
  gene_full_name: C-X-C Motif Chemokine Receptor 5
  perturbation_type: overexpression
  context: tumor_infiltrating
  phenotype_changes:
  - parameter: tertiary_lymphoid_structure_formation
    direction: increase
    effect_size: 0.6
    confidence: medium
  - parameter: tumor_infiltration
    direction: increase
    effect_size: 0.5
    confidence: medium
  cellswarm_mapping:
    behavior_changes:
      migrate: 0.2
      signal: 0.1
    state_changes:
      activation: 0.15
  evidence:
  - description: B cells in tertiary lymphoid structures predict immunotherapy response.
      Helmink et al. Nature 2020
    pmid: '31942075'
    pmid_verified: true
  notes: CXCR5+ B cells home to TLS; TLS presence correlates with better immunotherapy
    outcomes
